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1. Introduction 
In this chapter, we propose the use of the Cognitive Behavioral Analysis System for 
Psychotherapy as a group modality in the treatment of co-morbid chronic depression and 
posttraumatic stress disorder. CBASP has been found to be effective for the treatment of 
chronic depression and the functional impairments often associated with this disorder (i.e., 
pessimism, sense of failure, lack of satisfaction, guilt, sense of punishment, self-hate, self-
accusations, irritability, social withdrawal, indecisiveness, work inhibition, sleep 
disturbance, loss of appetite, weight loss, somatic preoccupation, and loss of libido, etc.). 
[1,2,3,4,5,6]. Although large studies such as Klien et al. [6,7,8] have focused on individual 
treatment for which it was developed, CBASP has been shown to be feasible as a group 
treatment in U.S., Canada, and in Germany. Clinical application of group CBASP in the U.S., 
thus far, has focused on combat veterans, who have been shown to be particularly 
vulnerable to Posttraumatic stress disorder (PTSD) and chronic depression [9]. We will 
outline the nature of these often chronic, co-existing symptoms and then present the 
rationale. For group CBASP interventions with co-morbid population. 
The rationale for developing a group protocol for CBASP is based on a number of variables. 
For example, group involvement for chronically depressed patient reduces social isolation 
which limits opportunities to experience social interaction and new learning. In addition, 
interactions among patients with similar symptoms and experiences may create 
opportunities for validation, belonging, and the generation of hope that may not be as 
strong in individual psychotherapy. Group interactions also provide an in-vivo learning 
environment that maximizes interpersonal exposure and enhances social skill development. 
We have found that peer modeling has a positive impact on attendance as well as increased 
compliance with assignments and in session participation. Finally, within the VA Healthcare 
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System where we have treated combat veterans, the provision of. Group psychotherapy 
allows greater access to treatment for growing numbers of veterans seeking help.  
The rationale for developing a group format for this established, evidence-based treatment 
for chronic depression stems, in part, from the need for greater access to treatment for 
increasingly numbers of veterans returning from combat with PTSD and MDD symptoms. 
Group methodologies have been shown to be very effective in working with homogeneous 
populations, both in terms of cultural characteristics and symptom presentation [10]. In fact, 
veterans share a distinct military culture and as such report a “bond” and increased sense of 
cohesion with the experiences of each other than they do with most civilians [11]. Utilizing 
this commonality to enhance a sense of social connection and support as well as counteract 
patterns of interpersonal avoidance may improve treatment outcomes for this frequently 
treatment resistant population.  
In a meta-analysis of 48 group therapy studies of depression treatment, McDermut, Miller, 
Brown [12] found that patients treated in group modalities reported a significant reduction 
in depressive symptoms when compared to 85% of untreated patients. In studies exploring 
the benefits of culturally relevant intervention strategies, Ginder and Smith [13] found that 
when group interventions with homogeneous cultural groups, they were four times more 
effective than groups that were culturally nonspecific.  
2. Problem statement 
2.1. Co-morbid MDD and PTSD 
Veterans often present with a co-morbid symptom presentation, and co-morbid symptom 
expression has demonstrated poorer treatment outcomes across psychopathologies [14,15]. 
The co-morbidities of chronically depressed individuals include anxiety disorders and 
substance dependence, somatic and physiological disorders and include a range of personality 
disorders [16,17]. Understanding how these various symptom structures and clinical 
presentations relate, and developing effective strategies for addressing clinical concerns is 
paramount, if we hope to effectively treat patients with co-morbid depression and PTSD.  
We are focusing on the co-occurrence of chronic depression and chronic posttraumatic stress 
disorder (PTSD), because it represents the most common co-occurring symptom set for 
males (48%) and females (49%) of any Axis I disorders, with the exception of PTSD and 
alcohol abuse for males (51%) [18]. This co-morbidity has also become increasingly critical to 
our understanding of the etiology of chronic depression from a developmental perspective. 
For the patient presenting with early onset chronic depression we can typically find a 
developmental profile of maltreatment in the form of emotional abuse or neglect, physical 
abuse or neglect, and sexual abuse [19]. However, interpersonal maltreatment is not the only 
childhood traumatic experience occurring within the context of family and caregiver 
relationships, individuals are also subject to a range of losses or “psychological insults” [20], 
such as warfare, sociopolitical stressors, and environmental disasters. These stressors often 
have a negative impact on individuals’ views of themselves, others, and their world [20].  
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The foundational derailment of secure attachments and normative cognitive-affective 
development produces negative self-other attributions and an enhanced fear response 
toward unfamiliar or threatening environmental stimuli. Behaviorally, this is manifested in 
a predominantly avoidant coping strategy, which, in turn, increases the strength of the fear 
structure [21]. Chronic depressive trajectories of late onset or adult traumatic events have 
received less attention in the literature and yet represent approximately 8% of the 
chronically depressed adult population. For instance, over 50% of military veterans 
diagnosed with PTSD carry a diagnosis of depression lasting for two or more years with no 
evidence of depressive disorder prior to their military duty [22,9]. This co-morbid 
PTSD/chronically depressed population has a high treatment refractory rate for both 
antidepressant medication and psychosocial interventions [23]. 
PTSD is a chronic often disabling disorder that affects approximately 6.8% of the U.S. 
population with a lifetime prevalence of 3.6% for males, and 9.7% for females [18]. In the 
Veterans Health Study [22] it was shown that 31% of the over 2,000 veterans sampled, had 
experienced significant depressive symptoms with 54% of these depressed veterans 
evidencing one or more psychiatric co-morbidity, predominantly PTSD. Additionally, 88% 
had medical co-morbidities such as hypertension, heart disease, diabetes, and degenerative 
joint disease. The lifetime prevalence of Major Depressive Disorder in patient populations 
such as combat veterans who have a diagnosis of PTSD has been reported to be as high as 
68%[24]. Large community sample co-morbidity research has demonstrated that individuals 
who have PTSD are 3-5 times more likely to develop Major Depressive Disorder over their 
lifetime [18]. There is a complex interaction among neurobiological and psychosocial factors 
that involve the overactivation of the hypothalamic-pituitary-adrenal axis [25]. While the 
empirical literature has begun to outline the interaction of these two disorders, most of the 
treatment literature focuses on effective interventions with either MDD or PTSD alone. This 
presents a gap in our understanding about how to treat patients with co-morbid chronic 
depression/PTSD.  
That we are treating interacting disorders rather than two separate or sequential disorders 
complicates both treatment and the evidence base of the treatment modality, which is 
based on data from single diagnosis samples. Regarding the complexity of treatment, the 
clinician has, in the case of PTSD, the treatment goal of reducing patients' trauma 
symptoms when their motivation is poor and their coping strategies (i.e., avoidance, 
substance abuse, anger) are maladaptive and entrenched. When treatment for chronic 
depression is linked to that of PTSD, treatment can be compromised and derailed by the 
expression of trauma symptoms that may undermine the patient’s sense of safety and trust 
and reduce treatment adherence.  
As clinicians working in the Veterans Administration HealthCare System, we have noted 
that when these disorders co-occur, patients report greater symptom distress, treatment 
interventions can become highly problematic, and/or patients become treatment refractory 
[23]. Although first-line PTSD treatments, such as Prolonged Exposure Therapy (PE) and 
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Cognitive Processing Therapy (CPT) for non-comorbid PTSD report a remission of acute 
depressive symptoms when PTSD symptoms are actively addressed, some chronically 
depressed patients find it difficult to engage in and complete trauma focused therapies that 
activate traumatic memories and require adherence to between-session imaginal and in-vivo 
exposures. This problem may be reflected in a 23% drop-out rate for civilians receiving 
trauma-focused therapy and as high as 30% dropout for veterans with PTSD. Many of these 
veterans had co-occurring disorders, including MDD [24].  
3. Application area 
3.1. CBASP group application 
The adaption of CBASP to a group treatment maintains the core structure and principles of 
the individual treatment while expanding on behavioral skill development and behavioral 
activation. The structure of the CBASP group follows the outline provided below, which 
provides for pretreatment screening and education, treatment measures and co-construction 
of the transference hypothesis, which is generalized to the impact on the group environment 
rather than specifically on the therapist as in individual CBASP treatment. 
3.2. Pre-treatment interview 
Screening and Baseline measures 
 Interview and differential diagnosis MINI v6,  
 Significant Other History (SOH), Transference Hypothesis 
 Beck Depression Inventory -II  
 CBASP Interpersonal Questionnaire (CIQ) 
 Depression Timeline 
 Interpersonal Impact Inventory (IMI)  
 Interpersonal Inventory of Problems (IIP) 
3.3. Session structure 
 Check-in (mood and activity level)               10 minutes 
 Presentation of Coping Questionnaire *           50 minutes 
 New learning, i.e., behavioral skills,              20 minutes 
 Consolidation of new learning                  10 minutes 
 Assignment and troubleshooting 
*Each member is responsible for 3 CQs each week. 
3.4. Session 1-6 initial phase 
Primary focus is on the development of Situational Analysis using the Coping Questionnaire: 
 Situational “slice of time” 
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 Development of narrative (beginning, mid, end points, behavioral focus) 
 Identify situational interpretations or “reads”        
 Actual Outcome=Desired Outcome  
 Remediation of interpretations and development of Action Interpretations 
 Generalization of learning  
Introduction of Behavioral Activation - Daily monitoring sheet and identification of 
depressant vs. antidepressant behaviors 
3.5. Sessions 6-10 early treatment 
Continued review of Situational Analyses, and Future Situational Analyses with focus on 
developing new behavioral skills.  
 Active listening/communication skills 
 Assertiveness  
 Emotion Regulation skills 
 Monitoring and incremental increase antidepressant activities 
  Role plays to practice new interpersonal behaviors generated in group, i.e., “let’s try 
that out and see how it works” 
3.6. Session 10-12 mid- treatment 
Situational Analyses and Future Situational Analyses with focus on:  
 Interpersonal Impact Inventory (IMI) 
 Identification of interpersonal “hot spots” related to Significant Other History 
transference hypothesis for each group member. 
 Focus on behavioral manifestation of transference hypothesis in interpersonal life. 
 Link behaviors to circumplex – role play alternative behaviors, and cognitions  that 
mediate interpersonal “pulls.”  
 Review the impact of behaviors on achieving Desired Outcomes 
3.7. Session 12-18 mid-treatment 
Situational Analyses and Future Situational Analyses with focus on:  
 Improving behavioral skills, i.e., behavioral activation, communication, 
assertiveness, emotion regulation 
 Complete Interpersonal Discrimination Exercise (IDE) based on Situational 
Analyses 
 Generalization and consolidation of new learning 
3.8. Session 18-24 late treatment 
CBASP skills are being practiced weekly: 
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 Situational Analysis and Future SAs 
 Interpersonal interactions and behavioral skills: Behavioral Activation, Active 
Listening, Assertiveness, Emotion regulation 
  Interpersonal Discrimination Exercise based on situational “hotspots”   
3.9. Sessions 24-28 termination and relapse prevention 
 Review of basic principles of learning theory and the issues related to extinction trial 
 Individualized behavioral practice plan, identification of roadblocks, supports, and 
contacts 
 Group feedback of individual gains, areas of vulnerability, and role in the group 
 Establish future meeting dates and support contacts 
4. Research course 
4.1. Method 
In a study conducted at the Ann Arbor Veterans Healthcare System, 52 male veterans, 
aged 55-66 with PTSD and MDD were treated using CBASP group therapy for 28 weeks 
[26]. A comparative sample of 45 male veterans, aged 49-62, were treated with a 
supportive therapy for the same number of sessions. There was exclusion criteria for 
psychosis/schizophrenia, bipolar disorder, and active substance abuse. In each of these 
group therapy conditions, chronic depression was the primary diagnosis, PTSD was 
secondary. All participants were on antidepressant medications and dosage was 
unchanged during the group intervention. Symptom measurement, using the BDI-II [27] 
and the PSTD Checklist-C [28] were given to all therapy participants at the beginning 
and end of treatment. These measures were again given at 1 month and 6 month follow-
up. 
4.2. Research results 
Data was collected and analyzed using SPSS version 18. Group data was compared using 
paired t-test. There was a significant improvement in the CBASP group, t (51) = 5.12, p< .004 
for depression and PTSD symptoms t (51) =3.24, p<.05, as compared to no significant change 
in the supportive treatment group t (44) = 1.15, ns (Figure 1).  
The CBASP group was measured at the end of 1 month post treatment and again after 6 
months post treatment to assertain the durability of the effects of treatment. The results of 
the treatment sessions and follow up measures on the BDI-II and PCL-C are seen in Figure 2. 
Depression symptoms demonstrated increase at 1 month and 6 month follow–up 
assessment compared to end of treatment level. The PCL-C continued to drop at 1 month 
and then showed a increase at 6 months. The increase for both the BDI-II and PCL-C during 
the follow up phase were that was nonsignificant. 
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Note: CBASP group N=52 and TAU group N=45. BDI=Beck Depression Inventory–II, PCL-C= PTSD Checklist-Civilian. 
Figure 1. CBASP and TAU Pre and Post scores on BDI-II and PCL-C  
 
Figure 2. CBASP mean scores on BDI-II and PCL-C (N=52) 
Figure 2 CBASP session scores on BDI-II and PCL-C with 1 and 6 months follow up. 
5. Limitations and future research 
The conclusions drawn from this sample of male veterans with chronic depressive 
disorders and co-morbid PTSD, demonstrates the feasibility of CBASP as a treatment for 
co-morbid MDD/PTSD with significant reductions in depression and PTSD symptoms 
compared to treatment as usual. The lack of randomization, absence of a control condition, 
and a relatively small effect size represent some of the limitations in this study. 
Nevertheless, the results suggest that using group CBASP to address co-morbid chronic 
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depression and PTSD provides a feasible means of addressing the complexities of these co-
occurring disorders. 
The direction of future research is focused on dismantling of the CBASP method to identify 
the relative power of the active mechanisms within the model as well as their 
interrelationship and impact on outcome. In addition, we are actively exploring different 
configurations and dosages of the group method to determine the most effective delivery 
system. This includes explore the added benefit of parallel individual CBASP sessions as 
well as providing twice weekly group sessions to see if these agumentations provide 
significant additive effects to weekly, group only sessions. We believe that it is essential to 
provide termination phase sessions that are paced to the patients‘ learning aquisition and 
consolidation. This may necessiate spread out session at the end of group treatment, with 
the expectation that this might minimize the extinction effect and symptom relapse. 
6. Conclusions 
CBASP group therapy shows promise in the facilitation of cognitive, emotional, and 
behavioral change by providing the opportunity for patients to process reactions with other 
group members who share similar life experiences. Pilot studies have shown CBASP to be 
feasible and effective in a group format [29] whether alone or in combination with 
individual therapy. In this chapter we have focused on culturally specific application for 
group CBASP to treat outpatients in US Veteran Administration Medical Centers; however, 
CBASP group is being studied in heterogeneous groups and inpatient applications in 
Canada, Germany the U.S. and UK. Data from this research will serve to inform clinicians as 
to relative effectiveness of this methodology within a group context, but will begin to 
address questions about CBASP’s therapeutic mechanisms and their role in promoting 
reduction in the symptoms of chronic depression. Beyond the potential advantages of 
CBASP groups in terms of greater treatment access and cost-effectiveness, there are the 
nonspecific factors such as enhanced social support, normalization of symptoms, and 
interpersonal skill development within a social context that make it a powerful foundation 
for behavioral change and a durable impediment to depression relapse. 
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